Sinovac Biotech Ltd (SVA) — Working Capital to Net Assets Ratio
Sinovac Biotech Ltd (SVA) has a Working Capital to Net Assets ratio of 88.4% as of June 2024. Working capital of $10.17 Billion (current assets of $11.15 Billion minus current liabilities of $978.45 Million) is measured against net assets of $11.51 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See debt-free asset ratio of Sinovac Biotech Ltd to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Sinovac Biotech Ltd Working Capital to Net Assets (1998–2023)
This chart shows how Sinovac Biotech Ltd's Working Capital to Net Assets ratio has evolved across 25 annual periods from 1998 to 2023. As of June 2024, the ratio stands at 88.4%, reflecting working capital of $10.17 Billion against net assets of $11.51 Billion USD. Check Sinovac Biotech Ltd (SVA) tangible net worth to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for Sinovac Biotech Ltd (1998–2023)
The table below presents the year-by-year Working Capital to Net Assets ratio for Sinovac Biotech Ltd from 1998 to 2023, covering 25 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see how much is Sinovac Biotech Ltd worth.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2023 | 88.9% | $10.68 Billion | $12.02 Billion | $11.83 Billion | $1.15 Billion | ▲ +2.1 pp |
| 2022 | 86.8% | $11.03 Billion | $12.71 Billion | $12.13 Billion | $1.09 Billion | ▼ -3.3 pp |
| 2021 | 90.1% | $12.50 Billion | $13.88 Billion | $14.92 Billion | $2.41 Billion | ▲ +11.5 pp |
| 2020 | 78.6% | $880.68 Million | $1.12 Billion | $1.56 Billion | $679.61 Million | ▲ +4.1 pp |
| 2019 | 74.5% | $262.41 Million | $352.19 Million | $349.61 Million | $87.20 Million | ▼ -2.9 pp |
| 2018 | 77.4% | $225.97 Million | $291.93 Million | $284.18 Million | $58.20 Million | ▲ +27.7 pp |
| 2017 | 49.7% | $64.48 Million | $129.67 Million | $130.75 Million | $66.26 Million | ▼ -2.7 pp |
| 2016 | 52.4% | $67.97 Million | $129.67 Million | $134.24 Million | $66.26 Million | ▲ +0.9 pp |
| 2015 | 51.5% | $70.36 Million | $136.50 Million | $128.49 Million | $58.14 Million | ▼ -1.4 pp |
| 2014 | 52.9% | $74.97 Million | $141.73 Million | $154.80 Million | $79.83 Million | ▼ -22.4 pp |
| 2013 | 75.3% | $108.09 Million | $143.64 Million | $157.25 Million | $49.16 Million | ▲ +1.0 pp |
| 2012 | 74.3% | $96.13 Million | $129.44 Million | $126.28 Million | $30.16 Million | ▲ +10.6 pp |
| 2011 | 63.7% | $92.51 Million | $145.30 Million | $132.04 Million | $39.53 Million | ▼ -5.1 pp |
| 2010 | 68.7% | $101.54 Million | $147.76 Million | $147.29 Million | $45.76 Million | ▼ -12.1 pp |
| 2009 | 80.9% | $68.30 Million | $84.47 Million | $119.31 Million | $51.01 Million | ▲ +9.4 pp |
| 2008 | 71.5% | $38.33 Million | $53.64 Million | $55.57 Million | $17.24 Million | ▲ +14.5 pp |
| 2007 | 57.0% | $18.74 Million | $32.90 Million | $39.18 Million | $20.44 Million | ▲ +10.6 pp |
| 2006 | 46.3% | $9.88 Million | $21.31 Million | $21.74 Million | $11.86 Million | ▲ +35.4 pp |
| 2005 | 11.0% | $1.81 Million | $16.51 Million | $8.47 Million | $6.66 Million | ▼ -0.7 pp |
| 2004 | 11.7% | $1.81 Million | $15.56 Million | $8.47 Million | $6.66 Million | ▲ +6.6 pp |
| 2003 | 5.0% | $545.87K | $10.89 Million | $3.95 Million | $3.41 Million | ▼ -24.7 pp |
| 2002 | 29.7% | $29.56K | $99.44K | $166.37K | $136.81K | ▼ -59.3 pp |
| 2001 | 89.0% | $-607.93K | $-682.96K | $165.62K | $773.55K | ▲ +0.0 pp |
| 2000 | 89.0% | $-607.93K | $-682.96K | $165.62K | $773.55K | ▼ -11.0 pp |
| 1998 | 100.0% | $29.01K | $29.01K | $33.51K | $4.50K | — |